Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Top Ponatinib Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Ponatinib Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 45mg
1.3.3 15mg
1.4 Market Segment by Application
1.4.1 Global Ponatinib Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 CML
1.4.3 ALL
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Ponatinib Revenue (2015-2026)
2.1.1 Global Ponatinib Revenue (2015-2026)
2.1.2 Global Ponatinib Sales (2015-2026)
2.2 Ponatinib Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Ponatinib Sales by Regions (2015-2020)
2.2.2 Global Ponatinib Revenue by Regions (2015-2020)
2.3 Global Top Ponatinib Regions (Countries) Ranking by Market Size
2.4 Ponatinib Industry Trends
2.4.1 Ponatinib Market Top Trends
2.4.2 Market Drivers
2.4.3 Ponatinib Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Ponatinib Players: Views for Future
3 Competitive Landscape by Manufacturers
3.1 Global Top Ponatinib Manufacturers by Sales (2015-2020)
3.1.1 Global Ponatinib Sales by Manufacturers (2015-2020)
3.1.2 Global Ponatinib Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Ponatinib Sales in 2019
3.2 Global Top Manufacturers Ponatinib by Revenue
3.2.1 Global Ponatinib Revenue by Manufacturers (2015-2020)
3.2.2 Global Ponatinib Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Ponatinib Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ponatinib as of 2019)
3.4 Global Ponatinib Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Ponatinib Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Ponatinib Market
3.7 Key Manufacturers Ponatinib Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Ponatinib Historic Market Review by Type (2015-2020)
4.1.2 Global Ponatinib Sales Market Share by Type (2015-2020)
4.1.3 Global Ponatinib Revenue Market Share by Type (2015-2020)
4.1.4 Ponatinib Price by Type (2015-2020)
4.1 Global Ponatinib Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Ponatinib Sales Forecast by Type (2021-2026)
4.2.3 Global Ponatinib Revenue Forecast by Type (2021-2026)
4.2.4 Ponatinib Price Forecast by Type (2021-2026)
5 Global Ponatinib Market Size by Application
5.1 Global Ponatinib Historic Market Review by Application (2015-2020)
5.1.2 Global Ponatinib Sales Market Share by Application (2015-2020)
5.1.3 Global Ponatinib Revenue Market Share by Application (2015-2020)
5.1.4 Ponatinib Price by Application (2015-2020)
5.2 Global Ponatinib Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Ponatinib Sales Forecast by Application (2021-2026)
5.2.3 Global Ponatinib Revenue Forecast by Application (2021-2026)
5.2.4 Ponatinib Price Forecast by Application (2021-2026)
6 North America
6.1 North America Ponatinib Breakdown Data by Company
6.2 North America Ponatinib Breakdown Data by Type
6.3 North America Ponatinib Breakdown Data by Application
6.4 North America Ponatinib Breakdown Data by Countries
6.4.1 North America Ponatinib Sales by Countries
6.4.2 North America Ponatinib Revenue by Countries
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Ponatinib Breakdown Data by Company
7.2 Europe Ponatinib Breakdown Data by Type
7.3 Europe Ponatinib Breakdown Data by Application
7.4 Europe Ponatinib Breakdown Data by Countries
7.4.1 Europe Ponatinib Sales by Countries
7.4.2 Europe Ponatinib Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Ponatinib Breakdown Data by Company
8.2 Asia Pacific Ponatinib Breakdown Data by Type
8.3 Asia Pacific Ponatinib Breakdown Data by Application
8.4 Asia Pacific Ponatinib Breakdown Data by Regions
8.4.1 Asia Pacific Ponatinib Sales by Regions
8.4.2 Asia Pacific Ponatinib Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Ponatinib Breakdown Data by Company
9.2 Latin America Ponatinib Breakdown Data by Type
9.3 Latin America Ponatinib Breakdown Data by Application
9.4 Latin America Ponatinib Breakdown Data by Countries
9.4.1 Latin America Ponatinib Sales by Countries
9.4.2 Latin America Ponatinib Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Ponatinib Breakdown Data by Type
10.2 Middle East and Africa Ponatinib Breakdown Data by Application
10.3 Middle East and Africa Ponatinib Breakdown Data by Countries
10.3.1 Middle East and Africa Ponatinib Sales by Countries
10.3.2 Middle East and Africa Ponatinib Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E
11 Company Profiles
11.1 ARIAD Pharmaceuticals
11.1.1 ARIAD Pharmaceuticals Corporation Information
11.1.2 ARIAD Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
11.1.3 ARIAD Pharmaceuticals Ponatinib Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 ARIAD Pharmaceuticals Ponatinib Products and Services
11.1.5 ARIAD Pharmaceuticals SWOT Analysis
11.1.6 ARIAD Pharmaceuticals Recent Developments
12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Ponatinib Sales Channels
12.2.2 Ponatinib Distributors
12.3 Ponatinib Customers
13 Estimates and Projections by Regions (2021-2026)
13.1 Global Ponatinib Sales Forecast (2021-2026)
13.1.1 Global Ponatinib Sales Forecast by Regions (2021-2026)
13.1.2 Global Ponatinib Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Ponatinib Sales Forecast (2021-2026)
13.2.2 North America Ponatinib Revenue Forecast (2021-2026)
13.2.3 North America Ponatinib Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Ponatinib Sales Forecast (2021-2026)
13.3.2 Europe Ponatinib Revenue Forecast (2021-2026)
13.3.3 Europe Ponatinib Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Ponatinib Sales Forecast (2021-2026)
13.4.2 Asia Pacific Ponatinib Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Ponatinib Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Ponatinib Sales Forecast (2021-2026)
13.5.2 Latin America Ponatinib Revenue Forecast (2021-2026)
13.5.3 Latin America Ponatinib Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Ponatinib Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Ponatinib Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Ponatinib Size Forecast by County (2021-2026)
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
【掲載企業】
ARIAD Pharmaceuticals
【免責事項】
https://www.globalresearch.jp/disclaimer